Human Molecular Genetics Advance Access originally published online on November 14, 2007
Human Molecular Genetics 2008 17(4):602-616; doi:10.1093/hmg/ddm334
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1
1 Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA 2 Department of Biotechnology, Maebashi Institute of Technology, Gunma 371-0816, Japan
* To whom correspondence should be addressed at: Center for Neurologic Diseases, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, MA 02115, USA. Tel: +1 6175255200; Fax: +1 6175255252; Email: dselkoe{at}rics.bwh.harvard.edu
Received June 25, 2007; Revised October 18, 2007; Accepted November 12, 2007
Mutations in the ubiquitously expressed gene PTEN-induced kinase 1 (Pink1) cause autosomal recessive Parkinson's disease. Pink1 encodes a putative serine/threonine kinase with an N-terminal mitochondrial targeting sequence. The mechanism that leads to selective degeneration of dopaminergic neurons via Pink1 mutations is unknown. A full-length pre-protein (66 kDa) and an N-terminally truncated mature form (55 kDa) have been described in human brain. Here, we report that the endogenous 66 kDa and 55 kDa Pink1 forms in cultured cells are not exclusive to mitochondria but also occur in cytosolic and microsome-rich fractions. Pink1 66 kDa is the predominant isoform in cultured cells. Using unbiased analyses of immunoisolated Pink1 complexes by mass spectrometry, co-immunoprecipitation and Hsp90 inhibitor studies, we identify Pink1 as a novel Cdc37/Hsp90 client kinase. This chaperone system influences both the subcellular distribution and the 66/55 kDa protein ratio of Pink1. PD-causing Pink1 mutations decrease whereas Parkin expression increases the Pink1 66/55 kDa protein ratio, biochemically linking Pink1 and Parkin and highlighting the potential relevance of this ratio for PD pathogenesis. Finally, we document the influence of Parkin on Pink1 subcellular distribution, providing further evidence for a common pathogenic pathway in recessive PD.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. K. Berger, G. P. Cortese, K. D. Amodeo, A. Weihofen, A. Letai, and M. J. LaVoie Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release Hum. Mol. Genet., November 15, 2009; 18(22): 4317 - 4328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Samann, J. Hegermann, E. von Gromoff, S. Eimer, R. Baumeister, and E. Schmidt Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth J. Biol. Chem., June 12, 2009; 284(24): 16482 - 16491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.F.L. van Nuenen, M. M. Weiss, B. R. Bloem, K. Reetz, T. van Eimeren, K. Lohmann, J. Hagenah, P. P. Pramstaller, F. Binkofski, C. Klein, et al. Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype Neurology, March 24, 2009; 72(12): 1041 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhou, Y. Huang, Y. Shao, J. May, D. Prou, C. Perier, W. Dauer, E. A. Schon, and S. Przedborski The kinase domain of mitochondrial PINK1 faces the cytoplasm PNAS, August 19, 2008; 105(33): 12022 - 12027. [Abstract] [Full Text] [PDF]
|
|